Ciaran P. Kelly, n/a

Beth Israel Deaconess Medical Center

Disclosure(s): Artugen: Advisor/Consultant; Facile Therapeutics: Advisor/Consultant; Ferring Pharma: Advisor/Consultant; Finch: Advisor/Consultant, Advisor/Consultant; First Light Biosciences: Advisor/Consultant, Ownership Interest; Milky Way Biosciences: Advisor/Consultant, Grant/Research Support; Pfizer: Advisor/Consultant; Seres Therapeutics: Advisor/Consultant; Summit Therapeutics: Advisor/Consultant

Poster(s):

• 221 - Assessment and Proposed Revision of Clinical Trial Clostridioides difficile Infection Clinical Response and Outcomes Definitions
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET